U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H22O4
Molecular Weight 302.3649
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ENTERODIOL

SMILES

OC[C@H](CC1=CC=CC(O)=C1)[C@H](CO)CC2=CC=CC(O)=C2

InChI

InChIKey=DWONJCNDULPHLV-HOTGVXAUSA-N
InChI=1S/C18H22O4/c19-11-15(7-13-3-1-5-17(21)9-13)16(12-20)8-14-4-2-6-18(22)10-14/h1-6,9-10,15-16,19-22H,7-8,11-12H2/t15-,16-/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H22O4
Molecular Weight 302.3649
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women.
2009-12
Weekly excretion of the mammalian lignan enterolactone in milk of dairy cows fed flaxseed meal.
2009-11
Gastrointestinal microflora, food components and colon cancer prevention.
2009-10
Quantitative aspects of the metabolism of lignans in pigs fed fibre-enriched rye and wheat bread.
2009-10
Occurrence of phytoestrogens in municipal wastewater and surface waters.
2009-08
Milk concentration of the mammalian lignan enterolactone, milk production, milk fatty acid profile, and digestibility in dairy cows fed diets containing whole flaxseed or flaxseed meal.
2009-08
Biotransformation of sesaminol triglucoside to mammalian lignans by intestinal microbiota.
2009-07-22
Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort.
2009-07-07
Tissue distribution and elimination of sesaminol triglucoside and its metabolites in rat.
2009-07
Bacterial conversion of secoisolariciresinol and anhydrosecoisolariciresinol.
2009-07
Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
2009-06-02
Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.
2009-05-05
Plasma enterolignans are not associated with nonfatal myocardial infarction risk.
2009-03
Phytoestrogens and phytoestrogen metabolites differentially modulate immune parameters in human leukocytes.
2008-12
Fecal and urinary lignans, intrafollicular estradiol, and endometrial receptors in lactating dairy cows fed diets supplemented with hydrogenated animal fat, flaxseed or sunflower seed.
2008-12
Effect of the form of the sesame-based diet on the absorption of lignans.
2008-12
Phytoestrogen content of foods of animal origin: dairy products, eggs, meat, fish, and seafood.
2008-11-12
Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study.
2008-10
Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
2008-09-01
Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice.
2008-09
An amphioxus orthologue of the estrogen receptor that does not bind estradiol: insights into estrogen receptor evolution.
2008-07-25
Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem.
2008-06-25
Effects of metabolites of the lignans enterolactone and enterodiol on osteoblastic differentiation of MG-63 cells.
2008-06
Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia.
2008-06
Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects.
2008-06
Genome analysis of food grade lactic Acid-producing bacteria: from basics to applications.
2008-05
Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells.
2008-05
Urinary excretion of 13 dietary flavonoids and phenolic acids in free-living healthy subjects - variability and possible use as biomarkers of polyphenol intake.
2008-04
Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study.
2008-03-15
Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women.
2008-02-12
Lignan content of selected foods from Japan.
2008-01-23
Determination of urinary phytoestrogens by HPLC-MS/MS: a comparison of atmospheric pressure chemical ionization (APCI) and electrospray ionization (ESI).
2008-01-01
Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.
2008
Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial.
2007-11-07
Enantioselective oxidation of enterodiol to enterolactone by human intestinal bacteria.
2007-11
Enantioselective dehydroxylation of enterodiol and enterolactone precursors by human intestinal bacteria.
2007-11
Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community.
2007-08
Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?
2007-07
Role of dietary lignans in the reduction of breast cancer risk.
2007-07
Determination of mammalian lignans in biological samples by modified gas chromatography/mass spectrometry.
2007-06-22
High throughput quantification of phytoestrogens in human urine and serum using liquid chromatography/tandem mass spectrometry (LC-MS/MS).
2007-06-15
Tissue distribution of lignans in rats in response to diet, dose-response, and competition with isoflavones.
2007-06-13
Isolation and characterization of a human intestinal bacterium, Eubacterium sp. ARC-2, capable of demethylating arctigenin, in the essential metabolic process to enterolactone.
2007-05
Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo.
2007-02-01
Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women.
2007-02
Urinary phytoestrogen excretion of rats bearing methylnitrosourea-induced mammary carcinoma in response to treatment with 2-methoxyestradiol.
2007-02
Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls.
2007-01
Clostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside.
2007-01
Lignans and human health.
2007
Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk.
2006
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:56:05 GMT 2025
Edited
by admin
on Mon Mar 31 19:56:05 GMT 2025
Record UNII
BZF4X2AWRP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ENTERODIOL
Common Name English
(-)-ENTERODIOL
Preferred Name English
(2R,3R)-2,3-BIS((3-HYDROXYPHENYL)METHYL)BUTANE-1,4-DIOL
Systematic Name English
Code System Code Type Description
PUBCHEM
115089
Created by admin on Mon Mar 31 19:56:05 GMT 2025 , Edited by admin on Mon Mar 31 19:56:05 GMT 2025
PRIMARY
EPA CompTox
DTXSID0047876
Created by admin on Mon Mar 31 19:56:05 GMT 2025 , Edited by admin on Mon Mar 31 19:56:05 GMT 2025
PRIMARY
MESH
C029498
Created by admin on Mon Mar 31 19:56:05 GMT 2025 , Edited by admin on Mon Mar 31 19:56:05 GMT 2025
PRIMARY
WIKIPEDIA
ENTERODIOL
Created by admin on Mon Mar 31 19:56:05 GMT 2025 , Edited by admin on Mon Mar 31 19:56:05 GMT 2025
PRIMARY
FDA UNII
BZF4X2AWRP
Created by admin on Mon Mar 31 19:56:05 GMT 2025 , Edited by admin on Mon Mar 31 19:56:05 GMT 2025
PRIMARY
CAS
80226-00-2
Created by admin on Mon Mar 31 19:56:05 GMT 2025 , Edited by admin on Mon Mar 31 19:56:05 GMT 2025
PRIMARY